WMA Declaration of Helsinki – Ethical Principles f... ...
Mark Cuban: A Master Disrupter for American Health...
Ask the Heart Doctor | Heart Valve Disease and Sur...
A Professional Overview of Hypertension ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
Scientists uncover genetic cause of rare autoimmune disorder...
October 09,2024 0
Survey indicates sugar and carbohydrate claims affect consum...
December 31,2024 0
Wearable brain imaging device shines a light on how babies r...
September 23,2024 0
Advancements in Digital Pathology: The Role of AI and Large ...
August 19,2024 0
Pelage Pharmaceuticals Advances Hair Loss Treatment with Pha...
August 14,2024 0
Why isn’t dental health considered primary medical care?...
August 17,2024 0
Category
Oncology
Cardiology & Vascular Surgery
Gastroenterology
Pediatrics
Hematology&Oncology
Ophthalmology
Medicine
Plastic Surgery
Medical research
Sleep
Most Read
Study finds bone injections don't improve survival over IV in cardiac arrest treatment

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
Cardiovascular Diseases November 27,2024 0
Study finds bone injections don't improve survival over IV in cardiac arrest treatment

Study finds bone injections don't improve survival over IV in cardiac arrest treatment

byUniversity of WarwickCredit: Pixabay/CC0 Public DomainAdministrating life-saving drugs for cardiac arrest directly into the bone does not improve survival rates compared to the standard intrav
Cardiovascular Diseases November 27,2024 0
Science-2024 Breakthrough of the Year：The long shot

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Medicial Breakthroughs December 13,2024 0
Science-2024 Breakthrough of the Year：The long shot

Science-2024 Breakthrough of the Year：The long shot

An innovative injectable HIV drug, lenacapavir, has shown significant effectiveness in preventing infections, offering a promising new breakthrough in the fight against the virus.
Medicial Breakthroughs December 13,2024 0
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Can a twice-a-year shot help end the HIV...
Reprogramming Stem Cells Could Cure Type...
More News
Chronic pain, opioids and natural benzos: Researchers discover how body can make its own 'sleeping pills'

Chronic pain, opioids and natural benzos: Researchers discover how body can make its own 'sleeping pills'

byUniversity of Leeds(A) Schematic of superposition of sensory neuron somata and satellite glial cells (SGCs) within the dorsal root ganglion (DRG). (B) Detection of Dbi mRNA expression in human
Anesthesiology & Pain January 21,2025 0
Chronic pain, opioids and natural benzos: Researchers discover how body can make its own 'sleeping pills'

Chronic pain, opioids and natural benzos: Researchers discover how body can make its own 'sleeping pills'

byUniversity of Leeds(A) Schematic of superposition of sensory neuron somata and satellite glial cells (SGCs) within the dorsal root ganglion (DRG). (B) Detection of Dbi mRNA expression in human
Anesthesiology & Pain January 21,2025 0
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT
Hematology&Oncology January 21,2025 0
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT
Hematology&Oncology January 21,2025 0
Oncologist discusses treating liver cancer

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver
Hematology&Oncology January 21,2025 0
Oncologist discusses treating liver cancer

Oncologist discusses treating liver cancer

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainLiver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be diagnosed with liver
Hematology&Oncology January 21,2025 0
Breast cancer risk increases with weight gain after age 35, finds study

Breast cancer risk increases with weight gain after age 35, finds study

by Elana GotkineThe risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recentlypublishedinCancer Biology & Medicine.Katherine
Hematology&Oncology January 21,2025 0
Breast cancer risk increases with weight gain after age 35, finds study

Breast cancer risk increases with weight gain after age 35, finds study

by Elana GotkineThe risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recentlypublishedinCancer Biology & Medicine.Katherine
Hematology&Oncology January 21,2025 0
Scientists uncover protein that helps cancer cells dodge CAR T cell therapy

Scientists uncover protein that helps cancer cells dodge CAR T cell therapy

byCity of Hope National Medical CenterStructure showing the targetable sites of the City of Hope-discovered YTHDF2 protein. Credit: Dr. Jianjun Chen's Lab / City of HopeScientists at City of
Hematology&Oncology January 21,2025 0
Scientists uncover protein that helps cancer cells dodge CAR T cell therapy

Scientists uncover protein that helps cancer cells dodge CAR T cell therapy

byCity of Hope National Medical CenterStructure showing the targetable sites of the City of Hope-discovered YTHDF2 protein. Credit: Dr. Jianjun Chen's Lab / City of HopeScientists at City of
Hematology&Oncology January 21,2025 0
Coffee and tea linked to lower head and neck cancer risk

Coffee and tea linked to lower head and neck cancer risk

byWileyCredit: Pixabay/CC0 Public DomainIn an analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancer, includin
Hematology&Oncology January 21,2025 0
Coffee and tea linked to lower head and neck cancer risk

Coffee and tea linked to lower head and neck cancer risk

byWileyCredit: Pixabay/CC0 Public DomainIn an analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancer, includin
Hematology&Oncology January 21,2025 0
Proof-of-concept study bioengineers therapeutics for improved cancer treatment

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut
Hematology&Oncology January 21,2025 0
Proof-of-concept study bioengineers therapeutics for improved cancer treatment

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut
Hematology&Oncology January 21,2025 0
Survival rates for incurable larynx cancer investigated for first time

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it
Hematology&Oncology January 21,2025 0
Survival rates for incurable larynx cancer investigated for first time

Survival rates for incurable larynx cancer investigated for first time

byNewcastle UniversityKaplan Meier Survival Curves with associated estimated survival rates for entire cohort. Credit:Clinical Otolaryngology(2024). DOI: 10.1111/coa.14260First-of-it
Hematology&Oncology January 21,2025 0
Detroit cancer center unveils new device for treating liver cancer at home

Detroit cancer center unveils new device for treating liver cancer at home

by Julia CardiCredit: Unsplash/CC0 Public DomainA new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announce
Hematology&Oncology January 21,2025 0
Detroit cancer center unveils new device for treating liver cancer at home

Detroit cancer center unveils new device for treating liver cancer at home

by Julia CardiCredit: Unsplash/CC0 Public DomainA new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announce
Hematology&Oncology January 21,2025 0
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x
Hematology&Oncology January 21,2025 0
Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x
Hematology&Oncology January 21,2025 0
More News
Week’s Top
Podcasts
... Breakthrough in Brain-Machine Interface: Chinese “Thought Communication” Becomes Reality Compared to decoding English’s 26 letters, decoding Chinese with its “418 syllables and 4 tones” presents a higher difficulty. ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Health spending has been rising across rich countries with different systems ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
APP
Medicine.net
Meditionary
PanWriting
PanDraw